Because the association between IDH mutations and the survival of patients with chondrosarcomas is still controversial [1, 9, 22, 28, 32, 50, 51], we decided to explore the pattern of IDH mutations in patients with chondrosarcoma and its relationship with clinical outcomes. The gene discussed is IDH2; the disease is chondrosarcoma.